---
title: "IV Medications Elsevier - Reviews, Revenue and Downloads in United States | Apple App Store"
description: "&quot;Try before you buy&quot; - Download the FREE App, which includes sample content. In-App purchase required to unlock all content.  For nearly 50 years - #1 IV drug handbook to safely administer more than 4"
---

# IV Medications Elsevier — United States
> #1 IV Drug Handbook - 50 years

![IV Medications Elsevier App Icon](https://is1-ssl.mzstatic.com/image/thumb/Purple221/v4/73/3b/f1/733bf1a4-572a-c258-fb40-ba595a733e08/AppIcon-IVMed-0-1x_U007emarketing-0-5-0-85-220-0.png/434x0w.png)

**Developer:** [Skyscape Medpresso](https://apptail.io/developer/skyscape-medpresso-TF)
**Category:** Medical
**Rating:** 4.6/5 (71 ratings)
**Price:** Free
**Bundle ID:** com.medpresso.Lonestar.ivmed
**Store:** Apple App Store
**Country:** United States
**Version:** 5.8.5 (released 2026-01-16)
**Original Release:** 2017-01-26
**Languages:** English

**App Store Link:** [Download on Apple App Store](https://apps.apple.com/us/app/app/id1143476433)
**AppTail Page:** [https://apptail.io/app/iv-medications-elsevier-Hfcc/united-states](https://apptail.io/app/iv-medications-elsevier-Hfcc/united-states)

## IV Medications Elsevier Description
&quot;Try before you buy&quot; - Download the FREE App, which includes sample content. In-App purchase required to unlock all content.

For nearly 50 years - #1 IV drug handbook to safely administer more than 400 intravenous drugs! Drug monographs for 10-20 newly approved drugs by the FDA include the most current information

Elsevier’s Intravenous Medications: A Handbook for Nurses and Health Professionals has been a trusted resource for complete, accurate drug information in a concise, quick-access format. New to the 2026 edition are many new monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings.

New to this edition
- New drug monographs for approximately 10-20 newly approved drugs by the FDA provides readers with the most current drug information
- Each monograph updated as necessary with new interactions, precautions, alerts, patient teaching instructions, and other need-to-know information. Current information helps nurses feel confident in the accuracy of the information and helps prevent medication dispensing errors

Key Features
- Annual publication prevents users from referencing outdated information
- 40-year history of impeccable accuracy reinforces the importance of safe IV drug administration
- Monographs on more than 400 IV drugs offers an impressive breadth of coverage that goes well beyond any comparable drug reference
- Proven, clinically-optimized page layout keeps all dosage information for each drug on either a single page or a two-page spread to prevent hand contamination by having to turn a page
- Highlighted Black Box Warnings and relevant content make locating critical information fast and easy
- Special circumstances in blue-screened text call attention to important circumstances that may not warrant black box warnings
- Convenient, alphabetical format organizes all drug monographs by generic name, allowing users to find any drug in seconds
- Dilution and dosage charts within monographs provide quick access to essential clinical information
- Life stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients

Content licensed from printed edition ISBN-10: 0443269599
Content licensed from printed edition ISBN-13: 9780443269592

SUBSCRIPTION :
Please purchase a yearly auto-renewing subscription to receive content access and available updates.

Yearly auto-renewing payments- $49.99

Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes &amp; App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable.

If you have any questions or comments, email us any time: customersupport@skyscape.com or call 508-299-3000

Privacy Policy - 
Terms and Conditions - 

Author(s):Shelly Rainforth Collins, PharmD
Publisher:Elsevier Health Sciences

## IV Medications Elsevier Screenshots
- [Screenshot 1](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource211/v4/a1/ce/cc/a1cecc96-0e31-768f-39ab-30fcfa5d24af/iPad_01.png/2048x2732.png)
- [Screenshot 2](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource221/v4/04/62/eb/0462eb8a-dd67-a073-22e1-87001fa1d4e4/iPad_02.png/2048x2732.png)
- [Screenshot 3](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource211/v4/d9/72/77/d97277f4-2f17-ece6-95d9-6e2bfba84568/iPad_03.png/2048x2732.png)
- [Screenshot 4](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource211/v4/79/c9/86/79c986c0-2d4d-6206-b11a-776607f102b1/iPad_04.png/2048x2732.png)
- [Screenshot 5](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource221/v4/e3/23/fd/e323fde8-2c52-5a08-2521-4288519249b9/iPad_05.png/2048x2732.png)
- [Screenshot 6](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource211/v4/06/ff/9d/06ff9d19-911e-a8c0-e6f1-50b5012755fe/iPad_06.png/2048x2732.png)
- [Screenshot 7](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource221/v4/d5/2b/6a/d52b6a6a-4e9e-465c-23d3-e41d85e3173f/iPad_07.png/2048x2732.png)
- [Screenshot 8](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource221/v4/ae/87/bc/ae87bc0a-6651-3134-e845-1f446ae95645/iPad_08.png/2048x2732.png)
- [Screenshot 9](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource211/v4/72/c1/74/72c1741b-8cb1-9c50-6ed0-c29fde0f0461/iPad_09.png/2048x2732.png)
- [Screenshot 10](https://is1-ssl.mzstatic.com/image/thumb/PurpleSource221/v4/cb/67/00/cb670007-a7b7-bfdc-c872-7fc927d1e410/iPad_10.png/2048x2732.png)

## IV Medications Elsevier Rating Breakdown in United States
- 5 stars: 60 (85%)
- 4 stars: 6 (8%)
- 3 stars: 0 (0%)
- 2 stars: 0 (0%)
- 1 stars: 5 (7%)

## IV Medications Elsevier Reviews in United States

### *---- "Incorrect brand-generic conversions"
Searching and tapping unasyn opens amifostine instead of unasyn. 
Thankfully this was caught.

Edit: search “keppra” and the incorrect generic “lacosamide” comes up. This app is untrustworthy and can longer be used as reference.
-- Phrexy, 2019-11-27

### ***** "Drugs are current and updated"
The drug database updates with the actual publishers content. Peace of mind when dealing with newly approved FDA medications.
-- Rustybag, 2019-08-06

### *---- "Unreasonable full access price."
This app would be great if it wasn’t overpriced. $49.99 seems unreasonably high.
-- Andichdjay, 2017-11-25

[View all IV Medications Elsevier reviews and detailed analytics on AppTail](https://app.apptail.io/signup?utm_campaign=ai-crawl&amp;utm_content=reviews)

## IV Medications Elsevier In-App Purchases
| Item | Price |
|------|-------|
| Intravenous Medications 2022 | $49.99 |
| 15% Off-Elsevier IVMed 1Y Sub | $42.49 |
| 20% Off-Elsevier IVMed 1Y Sub | $39.99 |
| 25% Off-Elsevier IVMed 1Y Sub | $37.49 |
| Elsevier IV Med HBK 1Y Sub off | $39.99 |
| Elsevier’s IV Med HBK 1Y Sub | $49.99 |
| Elsevier’s IV Med HBK 6M Sub | $32.99 |
| Elsevier’s IV Med HBK 3/M Sub | $25.99 |


## IV Medications Elsevier Discovered Keywords
- iv drug compatibility
- mediquo
- iv medications
- mediquo pro
- iv medications elsevier

## Apps Similar to IV Medications Elsevier
- [Mosby&#039;s Drug Reference](https://apptail.io/app/mosbys-drug-reference-RjTb/united-states)
- [PEPID®](https://apptail.io/app/pepid-KJUb/united-states)
- [IV Medications Gahart](https://apptail.io/app/iv-medications-gahart-biuc/united-states)
- [Nurse&#039;s Drug Handbook](https://apptail.io/app/nurses-drug-handbook-hoAc/united-states)
- [Micromedex IV Compatibility](https://apptail.io/app/micromedex-iv-compatibility-GBYc/united-states)
- [BD Infusate Companion](https://apptail.io/app/bd-infusate-companion-cGUd/united-states)
- [RNotes®](https://apptail.io/app/rnotes-Hjme/united-states)
- [Pocket Infusion Calculator](https://apptail.io/app/pocket-infusion-calculator-WVwe/united-states)
- [Emergency Central](https://apptail.io/app/emergency-central-JEAe/united-states)
- [Nursing Drug Handbook - NDH](https://apptail.io/app/nursing-drug-handbook-ndh-Kjym/united-states)

## IV Medications Elsevier Available In
- [United States](https://apptail.io/app/iv-medications-elsevier-Hfcc/united-states)
- [Mexico](https://apptail.io/app/iv-medications-elsevier-Hfcc/mexico)
- [Italy](https://apptail.io/app/iv-medications-elsevier-Hfcc/italy)
- [Brazil](https://apptail.io/app/iv-medications-elsevier-Hfcc/brazil)
- [Philippines](https://apptail.io/app/iv-medications-elsevier-Hfcc/philippines)
- [Pakistan](https://apptail.io/app/iv-medications-elsevier-Hfcc/pakistan)
- [United Arab Emirates](https://apptail.io/app/iv-medications-elsevier-Hfcc/united-arab-emirates)
- [Australia](https://apptail.io/app/iv-medications-elsevier-Hfcc/australia)
- [South Korea](https://apptail.io/app/iv-medications-elsevier-Hfcc/south-korea)
- [Chile](https://apptail.io/app/iv-medications-elsevier-Hfcc/chile)
- [Saudi Arabia](https://apptail.io/app/iv-medications-elsevier-Hfcc/saudi-arabia)
- [Japan](https://apptail.io/app/iv-medications-elsevier-Hfcc/japan)
- [Canada](https://apptail.io/app/iv-medications-elsevier-Hfcc/canada)
- [Finland](https://apptail.io/app/iv-medications-elsevier-Hfcc/finland)
- [Thailand](https://apptail.io/app/iv-medications-elsevier-Hfcc/thailand)
- [United Kingdom](https://apptail.io/app/iv-medications-elsevier-Hfcc/united-kingdom)
- [Vietnam](https://apptail.io/app/iv-medications-elsevier-Hfcc/vietnam)
- [India](https://apptail.io/app/iv-medications-elsevier-Hfcc/india)
- [Singapore](https://apptail.io/app/iv-medications-elsevier-Hfcc/singapore)
- [Nigeria](https://apptail.io/app/iv-medications-elsevier-Hfcc/nigeria)
- [Egypt](https://apptail.io/app/iv-medications-elsevier-Hfcc/egypt)
- [Spain](https://apptail.io/app/iv-medications-elsevier-Hfcc/spain)
- [France](https://apptail.io/app/iv-medications-elsevier-Hfcc/france)
- [Greece](https://apptail.io/app/iv-medications-elsevier-Hfcc/greece)
- [Hong Kong SAR China](https://apptail.io/app/iv-medications-elsevier-Hfcc/hong-kong)
- [Croatia](https://apptail.io/app/iv-medications-elsevier-Hfcc/croatia)
- [Hungary](https://apptail.io/app/iv-medications-elsevier-Hfcc/hungary)
- [Indonesia](https://apptail.io/app/iv-medications-elsevier-Hfcc/indonesia)
- [Ireland](https://apptail.io/app/iv-medications-elsevier-Hfcc/ireland)
- [Israel](https://apptail.io/app/iv-medications-elsevier-Hfcc/israel)
- [Iceland](https://apptail.io/app/iv-medications-elsevier-Hfcc/iceland)
- [Jamaica](https://apptail.io/app/iv-medications-elsevier-Hfcc/jamaica)
- [Kuwait](https://apptail.io/app/iv-medications-elsevier-Hfcc/kuwait)
- [Kazakhstan](https://apptail.io/app/iv-medications-elsevier-Hfcc/kazakhstan)
- [Lebanon](https://apptail.io/app/iv-medications-elsevier-Hfcc/lebanon)
- [Sri Lanka](https://apptail.io/app/iv-medications-elsevier-Hfcc/sri-lanka)
- [Luxembourg](https://apptail.io/app/iv-medications-elsevier-Hfcc/luxembourg)
- [Latvia](https://apptail.io/app/iv-medications-elsevier-Hfcc/latvia)
- [Madagascar](https://apptail.io/app/iv-medications-elsevier-Hfcc/madagascar)
- [North Macedonia](https://apptail.io/app/iv-medications-elsevier-Hfcc/north-macedonia)
- [Macao SAR China](https://apptail.io/app/iv-medications-elsevier-Hfcc/macau)
- [Malta](https://apptail.io/app/iv-medications-elsevier-Hfcc/malta)
- [Malaysia](https://apptail.io/app/iv-medications-elsevier-Hfcc/malaysia)
- [Netherlands](https://apptail.io/app/iv-medications-elsevier-Hfcc/netherlands)
- [Norway](https://apptail.io/app/iv-medications-elsevier-Hfcc/norway)
- [Nepal](https://apptail.io/app/iv-medications-elsevier-Hfcc/nepal)
- [New Zealand](https://apptail.io/app/iv-medications-elsevier-Hfcc/new-zealand)
- [Peru](https://apptail.io/app/iv-medications-elsevier-Hfcc/peru)
- [Portugal](https://apptail.io/app/iv-medications-elsevier-Hfcc/portugal)
- [Paraguay](https://apptail.io/app/iv-medications-elsevier-Hfcc/paraguay)
- [Qatar](https://apptail.io/app/iv-medications-elsevier-Hfcc/qatar)
- [Romania](https://apptail.io/app/iv-medications-elsevier-Hfcc/romania)
- [Russia](https://apptail.io/app/iv-medications-elsevier-Hfcc/russia)
- [Sweden](https://apptail.io/app/iv-medications-elsevier-Hfcc/sweden)
- [Slovenia](https://apptail.io/app/iv-medications-elsevier-Hfcc/slovenia)
- [Slovakia](https://apptail.io/app/iv-medications-elsevier-Hfcc/slovakia)
- [Poland](https://apptail.io/app/iv-medications-elsevier-Hfcc/poland)
- [Argentina](https://apptail.io/app/iv-medications-elsevier-Hfcc/argentina)
- [Austria](https://apptail.io/app/iv-medications-elsevier-Hfcc/austria)
- [Azerbaijan](https://apptail.io/app/iv-medications-elsevier-Hfcc/azerbaijan)
- [Belgium](https://apptail.io/app/iv-medications-elsevier-Hfcc/belgium)
- [Bulgaria](https://apptail.io/app/iv-medications-elsevier-Hfcc/bulgaria)
- [Bahrain](https://apptail.io/app/iv-medications-elsevier-Hfcc/bahrain)
- [Brunei](https://apptail.io/app/iv-medications-elsevier-Hfcc/brunei)
- [Belarus](https://apptail.io/app/iv-medications-elsevier-Hfcc/belarus)
- [Belize](https://apptail.io/app/iv-medications-elsevier-Hfcc/belize)
- [Switzerland](https://apptail.io/app/iv-medications-elsevier-Hfcc/switzerland)
- [Colombia](https://apptail.io/app/iv-medications-elsevier-Hfcc/colombia)
- [Cyprus](https://apptail.io/app/iv-medications-elsevier-Hfcc/cyprus)
- [Czechia](https://apptail.io/app/iv-medications-elsevier-Hfcc/czechia)
- [Germany](https://apptail.io/app/iv-medications-elsevier-Hfcc/germany)
- [Denmark](https://apptail.io/app/iv-medications-elsevier-Hfcc/denmark)
- [Dominican Republic](https://apptail.io/app/iv-medications-elsevier-Hfcc/dominican-republic)
- [Algeria](https://apptail.io/app/iv-medications-elsevier-Hfcc/algeria)
- [Ecuador](https://apptail.io/app/iv-medications-elsevier-Hfcc/ecuador)
- [Estonia](https://apptail.io/app/iv-medications-elsevier-Hfcc/estonia)
- [Uganda](https://apptail.io/app/iv-medications-elsevier-Hfcc/uganda)
- [Uruguay](https://apptail.io/app/iv-medications-elsevier-Hfcc/uruguay)
- [Uzbekistan](https://apptail.io/app/iv-medications-elsevier-Hfcc/uzbekistan)
- [South Africa](https://apptail.io/app/iv-medications-elsevier-Hfcc/south-africa)
- [Tunisia](https://apptail.io/app/iv-medications-elsevier-Hfcc/tunisia)
- [Türkiye](https://apptail.io/app/iv-medications-elsevier-Hfcc/turkey)
- [Taiwan](https://apptail.io/app/iv-medications-elsevier-Hfcc/taiwan)
- [Ukraine](https://apptail.io/app/iv-medications-elsevier-Hfcc/ukraine)
- [Senegal](https://apptail.io/app/iv-medications-elsevier-Hfcc/senegal)
- [Oman](https://apptail.io/app/iv-medications-elsevier-Hfcc/oman)
- [Grenada](https://apptail.io/app/iv-medications-elsevier-Hfcc/grenada)
- [Ghana](https://apptail.io/app/iv-medications-elsevier-Hfcc/ghana)

---

## About AppTail

[AppTail](https://apptail.io) is a mobile app intelligence platform providing app analytics, ASO (App Store Optimization) tools, keyword tracking, competitor analysis, revenue estimates, and review monitoring for iOS App Store apps. Track your app's performance, discover ranking keywords, monitor competitors, and analyze market trends.

- [Search Apps](https://apptail.io)
- [Top Charts](https://apptail.io/top-iphone-apps)
- [Sign Up for Full Access](https://app.apptail.io/signup?utm_campaign=ai-crawl&amp;utm_content=footer)

*Data provided by [AppTail](https://apptail.io) - Mobile App Intelligence Platform*
